ZA200707518B - Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3-Oxathiolane or pharmaceutically acceptable salts thereof
- Google Patents
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3-Oxathiolane or pharmaceutically acceptable salts thereof
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Canada IncfiledCriticalShire Canada Inc
Priority to ZA200707518ApriorityCriticalpatent/ZA200707518B/en
Publication of ZA200707518BpublicationCriticalpatent/ZA200707518B/en
ZA200707518A2005-03-142005-03-14Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3-Oxathiolane or pharmaceutically acceptable salts thereof
ZA200707518B
(en)
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3-Oxathiolane or pharmaceutically acceptable salts thereof
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3-Oxathiolane or pharmaceutically acceptable salts thereof
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3-Oxathiolane or pharmaceutically acceptable salts thereof
Novel 1,4-benzothiazepine-1, 1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
Process for the preparation of 1,3-dihydro-2H-3-benzazepin-2-one and application to the preparation of ivabradine and their pharmaceutically acceptable salts
Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3-Oxathiolane or pharmaceutically acceptable salts thereof
Methods of manufacturing stereoisomerically enriched (2s,3r)- n -(2-((3 - pyridinyl) methyl)-1-azabicyclo [2.2.2]oct -3 -yl) benzofuran-2-carboxamide and intermediates for use in the methods